Gastroenterology Doctors in East Greenwich, RI Accepting Medicare

5 Gastroenterology doctors found. Showing 1 - 5

Philip M. Trupiano, DO Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1351 S County Trl, Building 2 Suite 220, East Greenwich, RI 02818 Phone: 401-884-4040    Fax: 401-884-4010

Eric P. Berthiaume, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1407 South County Trail, Building 4 Suite 410, East Greenwich, RI 02818 Phone: 401-886-4040    Fax: 401-886-4010

John J. Cribb, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1407 South County Trail, Building 4 Suite 410, East Greenwich, RI 02818 Phone: 401-886-4040    Fax: 401-886-4010

Angela Fishman, D.O. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1407 S County Trl, Building 4 Suite 410, East Greenwich, RI 02818 Phone: 401-886-4040    Fax: 401-886-4010

Dr. Pedro Mariano Barros, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1407 S County Trl, Bldg #4 Suite 410, East Greenwich, RI 02818 Phone: 401-886-4040    Fax: 401-886-4010

News Archive

Ride of a Lifetime event officially certified as new Guinness World Record

Minneapolis' Target Center Arena was transformed into the world's largest cycling class today with the "Ride of a Lifetime." Hosted by Life Time Fitness, the event was officially certified as a new Guinness World Record™ by Guinness Official, Kimberly Partrick, who attended the event and made the live post-event proclamation.

Circular ‘Princess Leia' oscillations help sleeping brain consolidate memories

Every night while you sleep, electrical waves of brain activity circle around each side of your brain, tracing a pattern that, were it on the surface of your head, might look like the twin hair buns of Star Wars' Princess Leia.

Glenmark commences Revamilast Phase IIb trial in chronic inflammatory disorders

Glenmark Pharmaceuticals today announced that its Novel Chemical Entity "Revamilast" (GRC 4039) has initiated Phase IIb human dose range finding trials globally. Revamilast is an orally active, potent and selective inhibitor of phosphodiesterase 4 (PDE 4) that is currently being developed by Glenmark for the treatment of chronic inflammatory disorders such as Asthma, Rheumatoid Arthritis (RA) and other inflammatory diseases.

Researchers discover how Bcl-3 protein stops inflammation

Researchers at the University of Pennsylvania School of Medicine recently identified how a regulatory protein called Bcl-3 helps to control the body's inflammation response to infection by interfering a critical biochemical process called ubiquitination.

States take cautious approach to health law's new coverage mandates

Politico Pro reports that states are waiting to "get greater clarity" on the federal benefit package in order to minimize the extra coverage costs for which they might ultimately be responsible.

Read more Medical News

› Verified 3 days ago